Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News NYLI Healthy Hearts ETF HART

The Fund seeks investment results that correspond (before fees and expenses) generally to the price and yield performance of its underlying index, the IQ Candriam Healthy Hearts Index The Fund employs a passive management ¿ or indexing ¿ investment approach designed to track the performance of the Underlying Index, which was developed by IndexIQ LLC

Add To Watchlist

Recent & Breaking News (ARCA:HART)

IndexIQ Launches New ESG Core Plus Bond ETF "ESGB" in Partnership with MacKay Shields

Business Wire June 29, 2021

New York Life Investments and American Heart Association Introduce Thematic ESG ETF Focused on Health and Wellbeing

PR Newswire February 1, 2021

Harvard Apparatus Regenerative Technology Changes Name to Biostage, Inc. (NASDAQ: BSTG)

PR Newswire March 31, 2016

Bioengineered Organ Implant Developer HART Reviews Progress and Q4 2015 Results

PR Newswire March 17, 2016

Bioengineered Organ Implant Developer HART To Host Q4 2015 Conference Call Thursday, March 17th at 5:00pm ET

PR Newswire March 8, 2016

HART Appoints Laura Mondano as Vice President of Regulatory Affairs To Lead HART's 2016 IND Submission For its Bioengineered Organ Implant Solutions

PR Newswire March 2, 2016

HART, Developing Bio-Engineered Organs for Life Threatening Conditions, CEO Clip Video

Newsfile February 26, 2016

Bioengineered Organ Implant Developer HART to Webcast BIO CEO Conference Presentation Tues., Feb. 9th at 8:00 am EST

PR Newswire February 3, 2016

Bioengineered Organ Implant Developer HART to Webcast Source Capital Disruptive Growth & Healthcare Conference Presentation Wed., Feb. 10th at 3:30 pm EST

PR Newswire February 1, 2016

HART and Mayo Clinic Confirm Dates for Collaborative Large-Animal Bioengineered Organ Implant Surgeries

PR Newswire January 7, 2016

Bioengineered Organ Implant Developer HART to Webcast Biotech Showcase(TM) Presentation Monday, Jan. 11 at 2:00 pm PT

PR Newswire December 30, 2015

HART Secures Common Stock Purchase Facility with Aspire Capital

PR Newswire December 15, 2015

HART's CMO Dr. Saverio La Francesca to moderate panel on "Regenerative Engineering and Bio-Materials" at World Stem Cell Summit Saturday, Dec. 12

PR Newswire December 8, 2015

Bioengineered Organ Implant Company HART to Present at RegMed Capital Conference in Atlanta, Friday Dec. 11 at 9:00 am ET

PR Newswire December 3, 2015

HART Regains Compliance With Nasdaq Minimum Bid Price Listing Rule

PR Newswire November 30, 2015

Bioengineered Organ Implant Company HART to Webcast LD Micro Presentation in Los Angeles, Tues. Dec. 1st at 2:30 pm PT

PR Newswire November 25, 2015

Health-Care Defies Economic Conditions and Moves to New Highs - Broad Street Alerts

Accesswire November 17, 2015

HART Reports Q3 Financial Results and Provides Business Update

PR Newswire November 12, 2015

HART Reports Significant Confirmatory Results for its 2nd Generation Bioengineered Esophagus, Trachea and Bronchus Implants

PR Newswire November 12, 2015

Tissue Engineering Pioneer Dr. Joseph P. Vacanti Agrees to Chair New Scientific Advisory Board for Bioengineered Organ Developer HART

PR Newswire November 11, 2015